Pro-adrenomedullin is a predictive marker for all-cause mortality in stable COPD: An analysis of the COSYCONET study

S. Fähndrich (Freiburg, Germany), C. Herr (Homburg/Saar, Germany), H. Watz (Grosshansdorf, Germany), B. Waschki (Hamburg/Grosshansdorf, Germany), J. Classen (Homburg/Saar, Germany), J. Demandt (Homburg/Saar, Germany), F. Trudzinski (Heidelberg, Germany), A. Omlor (Homburg/Saar, Germany), F. Seiler (Homburg/Saar, Germany), T. Welte (Hannover, Germany), H. Kauczor (Heidelberg, Germany), R. Jörres (Munich, Germany), C. Vogelmeier (Marburg, Germany), R. Bals (Homburg/Saar, Germany)

Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Session: Novel findings in intensive care unit medicine: part 2
Session type: E-poster session
Number: 346
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Fähndrich (Freiburg, Germany), C. Herr (Homburg/Saar, Germany), H. Watz (Grosshansdorf, Germany), B. Waschki (Hamburg/Grosshansdorf, Germany), J. Classen (Homburg/Saar, Germany), J. Demandt (Homburg/Saar, Germany), F. Trudzinski (Heidelberg, Germany), A. Omlor (Homburg/Saar, Germany), F. Seiler (Homburg/Saar, Germany), T. Welte (Hannover, Germany), H. Kauczor (Heidelberg, Germany), R. Jörres (Munich, Germany), C. Vogelmeier (Marburg, Germany), R. Bals (Homburg/Saar, Germany). Pro-adrenomedullin is a predictive marker for all-cause mortality in stable COPD: An analysis of the COSYCONET study. 346

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study
Source: Eur Respir J, 55 (2) 1901314; 10.1183/13993003.01314-2019
Year: 2020



The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008



Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014



Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017

Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020


Clinical examination and all-cause mortality in non-mild COPD population – prospective study
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019


Validation of bode index as a predictor of mortality in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Mortality predictive variables in the short-term before a COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006

hsCRP is associated with 10-year mortality in COPD.
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020


A longitudinal study of the relationship between serial changes in BODE index, mortality and readmissions in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Mortality and prognostic factors in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014

Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

Analysis of NEWS2 trend to predict risk of death in COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis
Source: Eur Respir Rev, 29 (156) 190166; 10.1183/16000617.0166-2019
Year: 2020



Predictive factors of mortality in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007